BREWIN DOLPHIN LTD - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$5,666
-5.4%
2850.0%0.00%
Q2 2020$5,991
+71.9%
2850.0%0.00%
Q1 2020$3,486
-16.6%
2850.0%0.00%
Q4 2019$4,181
+9.9%
2850.0%0.00%
Q3 2019$3,805
-18.4%
2850.0%0.00%
Q2 2019$4,665
-4.2%
2850.0%0.00%
-100.0%
Q1 2019$4,868
+25.1%
2850.0%0.00%0.0%
Q4 2018$3,890
-52.3%
2850.0%0.00%0.0%
Q3 2018$8,157
+4.6%
2850.0%0.00%0.0%
Q2 2018$7,7982850.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders